简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-04-20 17:15 SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
2026-04-20 12:03 Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026
2026-04-20 11:50 Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program
2026-04-17 10:17 Seoul's Myeongdong Now Has a Clinic Where Tourists Get K-Beauty Treatments Between Shopping
2026-04-16 17:47 Got a Layover in Korea? This Clinic Near Incheon Airport Offers Aesthetic Treatments in Under 4 Hours
2026-04-16 17:38 Why Tens of Thousands of Foreign Patients Are Choosing This Gangnam Clinic
2026-04-16 15:31 Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building
2026-04-16 15:27 Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
2026-04-15 10:09 Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
2026-04-10 14:29 ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
2026-04-09 16:04 Americhem Announces Expansion of Global Healthcare Footprint with New China Investment at Chinaplas 2026
2026-04-09 13:35 Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
2026-04-08 10:12 Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis
2026-04-03 14:17 IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs
2026-04-02 13:44 Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
2026-04-02 13:39 VDYNE Receives FDA Approval to Initiate the TRIVITA1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System
2026-04-02 11:19 Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
2026-04-01 10:34 WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform
2026-04-01 09:38 Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
2026-03-31 10:48 HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

Business Wire Weibo

Press Releases

Latest Releases